Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
PHARMA DANCKAERT from Antwerpen, company number BE0418267166, closed financial year 2025 with a result of € -8,462 after tax. For that financial year PHARMA DANCKAERT recorded a gross margin of € 69,605 and equity of € 34,866. Compared with financial year 2024, the result moved from € -20,067 to € -8,462. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 9, 2026.
€ 34,866
▼ 20% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -8,462
▲ 58 % less loss than in 2024
Profit after tax over the fiscal year.
Loss, nothing to pay out
Reserves fell to € -15,134.
People and assets in 2025
0.8
Average over the fiscal year, from the social balance sheet.
€ 70,583
▲ 9% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 12,541
▲ 48% vs 2024
Loans from banks and other lenders, long and short.
€ 19,962
▼ 37% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,685
▼ 5% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 76,289 | € 56,028 | € 53,746 | € 69,605 | ▲ 30% |
| Profit after taxes | € -18,291 | € -15,077 | € -20,067 | € -8,462 | ▲ € 11,606 |
| Equity | € 78,472 | € 63,395 | € 43,328 | € 34,866 | ▼ 20% |
| Total debts | € 46,685 | € 51,969 | € 71,401 | € 97,420 | ▲ 36% |
| Cash | € 14,714 | - | - | - | |
| Retained profit | € 28,472 | € 13,395 | € -6,672 | € -15,134 | ▼ € 8,462 |
| Bank debt | € 0 | € 3,896 | € 8,483 | € 12,541 | ▲ 48% |
| Balance sheet total | € 125,157 | € 115,364 | € 114,729 | € 132,287 | ▲ 15% |
| Employees (FTE) | - | - | 0.8 | 0.8 |
Key figures of PHARMA DANCKAERT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMA DANCKAERT?
What happened at PHARMA DANCKAERT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 8,462. Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Antwerpen. KBO
In short
From € 18,291 loss in 2022 to € 8,462 loss in 2025.
A new publication or filing at PHARMA DANCKAERT? We notify you, reason included.
Follow PHARMA DANCKAERTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of VDG PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMA DANCKAERTBehind PHARMA DANCKAERT is Vdg Pharma BV. The shares are held by VDG PHARMA (100%).
Directors
According to the 2025 annual accounts
Director · represented by Anne-Catherina Verzele, Kristine De Groof
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Ter Heydelaan 173
2100 Antwerpen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0418.267.166
- VAT number
- BE 0418.267.166
- Registered office
- Ter Heydelaan 173, 2100 Antwerpen
- Names & denominations
- PHARMA DANCKAERT
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 April 1978
- Peppol
- Active · Active since 1 Oct 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers